YCL065W Antibody

What is YCL065W and why is it studied in yeast research?

YCL065W refers to a specific open reading frame (ORF) in the Saccharomyces cerevisiae genome, identified by its chromosomal location. The protein encoded by this gene has been the subject of various studies examining yeast molecular biology and genetics. Research involving YCL065W contributes to our broader understanding of fundamental cellular processes in eukaryotes, as S. cerevisiae serves as a model organism with conserved pathways relevant to human biology. Antibodies against YCL065W enable researchers to detect, quantify, and localize this protein within cellular contexts, facilitating studies on its expression, regulation, and function .

What types of YCL065W antibodies are available for research purposes?

The primary type of YCL065W antibody commercially available is a polyclonal antibody raised in rabbits against recombinant Saccharomyces cerevisiae (strain ATCC 204508/S288c) YCL065W protein. These antibodies are typically supplied in liquid form, containing preservatives such as 0.03% Proclin 300 and constituents including 50% glycerol and 0.01M PBS at pH 7.4. They are generally purified using antigen affinity methods and are classified as IgG immunoglobulins . Researchers should verify the specific validation data for their intended applications before use, as recommended by antibody validation repositories .

What are the validated applications for YCL065W antibodies?

YCL065W antibodies have been validated for specific research applications including Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB). These applications enable researchers to quantify and characterize the YCL065W protein in yeast samples. When selecting an antibody for a particular application, researchers should consult antibody data repositories that provide validation data specific to their experimental context . The validation process typically involves testing the antibody on known positive and negative samples to confirm specificity and sensitivity in the desired application.

How should YCL065W antibodies be stored to maintain optimal activity?

For optimal preservation of antibody activity, YCL065W antibodies should be stored at either -20°C or -80°C upon receipt. It is critical to avoid repeated freeze-thaw cycles, as these can degrade antibody quality and reduce binding efficacy. The antibodies are typically supplied in a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative, which helps maintain stability during proper storage . For laboratories preparing their own antibody dilutions or cocktails, proper labeling with preparation date, expiration date, and storage temperature is essential for maintaining quality control standards .

How can YCL065W antibody be incorporated into ChIP assays for studying chromatin association?

ChIP (Chromatin Immunoprecipitation) assays using YCL065W antibody can be implemented following similar protocols to those established for other yeast proteins. When designing a ChIP experiment with YCL065W antibody, researchers should consider:

• Crosslinking optimization: Typically using 1% formaldehyde for 10-15 minutes

• Sonication parameters: Adjusted to yield chromatin fragments between 200-600bp

• Antibody specificity: Pre-clearing lysates and including appropriate negative controls

• Quantification method: Real-time quantitative PCR is recommended for analyzing immunoprecipitated DNA

The experimental approach should be modeled after successful ChIP protocols such as those used for analyzing Htz1 association to promoters of genes like GAL1, SWR1, and ribosomal protein genes (RPL13A and RPS16B), where percentage of input DNA obtained by ChIP is calculated and compared between wild-type and mutant strains . This enables researchers to determine the chromosomal localization patterns of YCL065W protein and its potential interactions with specific genomic regions.

What considerations are important when designing co-immunoprecipitation experiments using YCL065W antibody?

When planning co-immunoprecipitation (Co-IP) experiments with YCL065W antibody, researchers should address several critical factors:

• Cell lysis conditions: Buffer composition should preserve protein-protein interactions while efficiently lysing yeast cells (typically requiring mechanical disruption)

• Antibody binding capacity: Determine optimal antibody-to-protein ratio through titration experiments

• Control experiments: Include both positive controls (known interacting proteins) and negative controls (IgG from the same species)

• Washing stringency: Balance between removing non-specific interactions and preserving genuine interactions

• Detection strategy: Western blotting with antibodies against suspected interaction partners

How can multi-parameter flow cytometry incorporate YCL065W antibody in yeast studies?

Implementing YCL065W antibody in multi-parameter flow cytometry for yeast research requires specific technical considerations:

• Cell wall digestion: Yeast cells require enzymatic treatment (typically with zymolyase or lyticase) to create spheroplasts permeable to antibodies

• Fixation protocol: Typically using 3.7% formaldehyde followed by permeabilization with a detergent such as 0.1% Triton X-100

• Antibody cocktail design: When combining YCL065W antibody with other antibodies, spectral overlap must be minimized

• Compensation controls: Single-stained controls for each fluorochrome are essential for accurate compensation

• Gating strategy: Sequential gating beginning with scatter properties to identify intact spheroplasts

For antibody cocktail validation, researchers must confirm that combining YCL065W antibody with other antibodies doesn't compromise detection sensitivity. This validation should include comparing staining patterns between individual antibodies and the cocktail using samples containing relevant positive and negative populations . The stability of antibody cocktails containing YCL065W antibody should be determined empirically, with particular attention to potential breakdown of tandem fluorochromes if included in the panel.

What is the recommended protocol for Western blotting with YCL065W antibody?

A comprehensive Western blotting protocol using YCL065W antibody should follow these methodological steps:

• Sample preparation:

  • Harvest yeast cells during logarithmic growth phase

  • Lyse cells using glass bead disruption in buffer containing protease inhibitors

  • Clear lysates by centrifugation (14,000 × g, 10 minutes, 4°C)

  • Quantify protein concentration using Bradford or BCA assay

• Gel electrophoresis and transfer:

  • Resolve 20-50 μg total protein on 10-12% SDS-PAGE

  • Transfer to PVDF membrane (recommended over nitrocellulose for yeast proteins)

  • Confirm transfer efficiency with reversible protein stain

• Antibody incubation:

  • Block membrane with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Incubate with YCL065W antibody at 1:1000 dilution in blocking buffer overnight at 4°C

  • Wash 3 × 10 minutes with TBST

  • Incubate with HRP-conjugated anti-rabbit secondary antibody at 1:5000 for 1 hour

  • Wash 3 × 10 minutes with TBST

• Detection and analysis:

  • Develop using enhanced chemiluminescence substrate

  • Analyze band intensity using image analysis software

  • Include loading control (e.g., Act1) for normalization

This protocol should be optimized for each specific research context, with particular attention to antibody dilution and incubation conditions .

How should researchers validate YCL065W antibody specificity?

A rigorous validation approach for YCL065W antibody specificity should include multiple complementary strategies:

• Genetic validation:

  • Test antibody reactivity in wild-type versus YCL065W deletion strains

  • Confirm loss of signal in knockout/deletion samples

• Epitope competition:

  • Pre-incubate antibody with excess immunizing peptide

  • Verify signal reduction/elimination in pre-blocked samples

• Multiple detection methods:

  • Compare results between Western blot, immunoprecipitation, and immunofluorescence

  • Consistency across methods strengthens specificity evidence

• Mass spectrometry validation:

  • Immunoprecipitate with YCL065W antibody

  • Confirm protein identity by mass spectrometry analysis

• Cross-reactivity assessment:

  • Test antibody against closely related yeast proteins

  • Evaluate potential off-target binding

Proper validation ensures experimental reproducibility and reliable data interpretation. Researchers should document validation results thoroughly and consider submitting data to antibody validation repositories to benefit the scientific community .

What controls are essential when using YCL065W antibody in immunofluorescence microscopy?

Immunofluorescence microscopy with YCL065W antibody requires a comprehensive set of controls:

• Primary antibody controls:

  • Positive control: Wild-type yeast strain known to express YCL065W

  • Negative control: YCL065W deletion strain

  • Isotype control: Non-specific rabbit IgG at equivalent concentration

• Secondary antibody controls:

  • Autofluorescence control: Unstained cells

  • Secondary-only control: Cells incubated with secondary antibody but no primary

• Fluorophore controls:

  • Single-fluorophore controls when performing multi-label experiments

  • Photobleaching controls for quantitative analysis

• Sample preparation controls:

  • Fixation control: Different fixation methods may affect epitope accessibility

  • Permeabilization control: Optimize detergent concentration

• Blocking efficacy controls:

  • Test different blocking agents (BSA, normal serum, commercial blockers)

Additionally, co-localization studies should include appropriate markers for cellular compartments to determine the subcellular localization of the YCL065W protein. Z-stack imaging is recommended to ensure complete visualization of three-dimensional structures within yeast cells.

How can researchers address weak or absent signal when using YCL065W antibody?

When encountering weak or absent signals with YCL065W antibody, systematic troubleshooting should include:

• Antibody concentration optimization:

  • Perform titration experiments using 2-fold serial dilutions

  • Test range from 1:500 to 1:5000 for Western blotting

  • Consider longer incubation times at more dilute concentrations

• Protein extraction method assessment:

  • Evaluate different lysis buffers for compatibility with YCL065W epitope

  • Test mechanical (glass beads) versus enzymatic (zymolyase) lysis methods

  • Include multiple protease inhibitors to prevent degradation

• Expression level considerations:

  • Confirm YCL065W expression under experimental conditions

  • Consider inducing expression if protein levels are naturally low

  • Use enrichment methods (e.g., subcellular fractionation) if necessary

• Detection system sensitivity:

  • Switch to more sensitive detection methods (e.g., from colorimetric to chemiluminescent)

  • Use signal enhancement systems (e.g., biotin-streptavidin amplification)

  • Consider longer exposure times for Western blots

• Antibody quality verification:

  • Test a new lot or alternative source of antibody

  • Verify storage conditions have been optimal

Creating a systematic troubleshooting table documenting each variable tested will facilitate identification of the problematic step in the protocol.

What strategies help differentiate between specific and non-specific binding of YCL065W antibody?

To distinguish specific from non-specific binding when using YCL065W antibody, researchers should implement these analytical approaches:

• Signal pattern analysis:

  • Specific binding produces distinct bands/patterns at expected molecular weights

  • Non-specific binding typically shows multiple bands or diffuse signals

• Comparative genetics approach:

  • Compare signal between wild-type and YCL065W deletion strains

  • Test in strains with YCL065W tagged with epitope tags (e.g., FLAG, HA)

• Competitive inhibition evaluation:

  • Pre-incubate antibody with excess immunizing peptide

  • Specific signals should be reduced/eliminated while non-specific signals persist

• Cross-validation with orthogonal methods:

  • Confirm findings using alternative detection methods

  • Compare with published localization/expression data for YCL065W

• Statistical analysis of replicates:

  • Quantify signal-to-noise ratio across multiple experiments

  • Apply appropriate statistical tests to determine significance

The interpretation should consider the biological context and expected expression pattern of YCL065W under the specific experimental conditions being studied.

How should researchers interpret unexpected molecular weight bands when using YCL065W antibody?

When unexpected molecular weight bands appear in Western blots with YCL065W antibody, systematic interpretation involves:

• Post-translational modification assessment:

  • Higher molecular weight bands may indicate ubiquitination, SUMOylation, phosphorylation

  • Lower bands may represent proteolytic cleavage products

  • Verify with specific inhibitors of modifications or proteases

• Isoform consideration:

  • Check databases for potential alternatively spliced variants

  • Compare with RNA-seq data for evidence of variant transcripts

• Experimental artifact evaluation:

  • Incomplete denaturation can cause aggregate formation

  • Sample overheating may cause protein degradation

  • Insufficient reducing agent can maintain disulfide bonds

• Cross-reactivity investigation:

  • Compare observed bands with predicted sizes of related proteins

  • Test antibody against purified related proteins

• Validation approach:

  • Immunoprecipitate protein and analyze by mass spectrometry

  • Compare results with tagged versions of YCL065W

A methodical investigation table documenting each unexpected band, potential explanations, and confirmatory experiments should be maintained to track the investigation process.

How can YCL065W antibody data be integrated with gene expression studies?

Integrating YCL065W antibody-based protein data with gene expression studies requires a multi-layered analytical approach:

• Correlation analysis protocol:

  • Quantify YCL065W protein levels via Western blot or ELISA

  • Measure YCL065W mRNA levels using RT-qPCR or RNA-seq

  • Calculate Pearson or Spearman correlation coefficients between protein and mRNA levels

  • Plot expression values and perform regression analysis

• Temporal dynamics assessment:

  • Design time-course experiments measuring both mRNA and protein

  • Calculate time delays between transcriptional and translational changes

  • Apply mathematical models to characterize protein production and degradation rates

• Condition-specific integration:

  • Compare protein-mRNA relationships across different growth conditions

  • Identify conditions where post-transcriptional regulation may be prominent

• Multi-omics data integration:

  • Combine with ribosome profiling data to assess translational efficiency

  • Incorporate proteomics data to position YCL065W within protein interaction networks

• Visualization strategies:

  • Generate heat maps showing protein and mRNA levels across conditions

  • Create scatter plots with mRNA on one axis and protein on the other

This integrated approach can reveal insights into the post-transcriptional regulation of YCL065W and identify conditions where protein levels deviate from what would be predicted by mRNA abundance alone .

What statistical approaches are recommended for analyzing quantitative data from YCL065W antibody experiments?

Robust statistical analysis of quantitative YCL065W antibody data should implement these methodological approaches:

• Normalization strategies:

  • Western blot: Normalize to loading controls (e.g., Act1, tubulin)

  • ELISA: Use standard curves with purified recombinant protein

  • Flow cytometry: Apply fluorescence minus one (FMO) controls for threshold setting

• Replicate analysis:

  • Minimum of three biological replicates recommended

  • Calculate means, standard deviations, and standard errors

  • Apply appropriate statistical tests based on data distribution:

    • Parametric: t-test (two conditions) or ANOVA (multiple conditions)

    • Non-parametric: Mann-Whitney U test or Kruskal-Wallis test

• Multiple testing correction:

  • Apply Bonferroni or Benjamini-Hochberg procedures when performing multiple comparisons

  • Report adjusted p-values alongside raw p-values

• Effect size calculation:

  • Report Cohen's d or fold changes rather than relying solely on p-values

  • Calculate confidence intervals for all measurements

• Power analysis:

  • Determine appropriate sample sizes based on expected effect sizes

  • Consider retrospective power analysis when interpreting negative results